Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience

Bhudia, 2022, The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer, Curr Treat Options Oncol, 23, 453, 10.1007/s11864-022-00961-5 Glynne-Jones, 2006, Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?, Br J Cancer, 94, 363, 10.1038/sj.bjc.6602960 Bahadoer, 2021, Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial, Lancet Oncol, 22, 29, 10.1016/S1470-2045(20)30555-6 Conroy, 2021, Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial, Lancet Oncol, 22, 702, 10.1016/S1470-2045(21)00079-6 Jin, 2022, Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR), J Clin Oncol, 40, 1681, 10.1200/JCO.21.01667 Cedermark, 1995, The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group, Cancer, 75, 2269, 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I Swedish Rectal Cancer, 1997, Improved survival with preoperative radiotherapy in resectable rectal cancer, N Engl J Med, 336, 980, 10.1056/NEJM199704033361402 Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580 Bujko, 2006, Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer, Br J Surg, 93, 1215, 10.1002/bjs.5506 Ngan, 2012, Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04, J Clin Oncol, 30, 3827, 10.1200/JCO.2012.42.9597 Glimelius, 2001, Preoperative radiotherapy for rectal cancer–is 5 x 5 Gy a good or a bad schedule?, Acta Oncol, 40, 958, 10.1080/02841860152708242 Allegra, 2015, Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial, J Natl Cancer Inst, 107, 10.1093/jnci/djv248 NCCN. Rectal Cancer V2. 2021. Marijnen, 2002, Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial, J Clin Oncol, 20, 817, 10.1200/JCO.2002.20.3.817 Peeters, 2005, Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients–a Dutch colorectal cancer group study, J Clin Oncol, 23, 6199, 10.1200/JCO.2005.14.779 Braendengen, 2011, Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study, Int J Radiat Oncol Biol Phys, 81, 1017, 10.1016/j.ijrobp.2010.07.007 Keane, 2020, International consensus definition of low anterior resection syndrome, ANZ J Surg, 90, 300, 10.1111/ans.15421 Bosset, 2004, Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group, Eur J Cancer, 40, 219, 10.1016/j.ejca.2003.09.032 Samuelian, 2012, Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer, Int J Radiat Oncol Biol Phys, 82, 1981, 10.1016/j.ijrobp.2011.01.051 van der Valk MJM, Marijnen CAM, van Etten B, Dijkstra EA, Hilling DE, Kranenbarg EMK, et al. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial (vol 147, pg 75, 2020). Radiotherapy and Oncology. 2020. 147:E1-E. Vitti ET, Parsons JL. The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair. Cancers (Basel). 2019. 11. Colaco, 2014, Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer, J Gastrointest Oncol, 5, 3 Moningi, 2019, Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies, Clin Transl Radiat Oncol, 19, 59, 10.1016/j.ctro.2019.08.004 Beltran, 2020, Radiation biology considerations of proton therapy for gastrointestinal cancers, J Gastrointest Oncol, 11, 225, 10.21037/jgo.2019.06.08 Beets-Tan, 2018, Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting, Eur Radiol, 28, 1465, 10.1007/s00330-017-5026-2 Valentini, 2016, International consensus guidelines on Clinical Target Volume delineation in rectal cancer, Radiother Oncol, 120, 195, 10.1016/j.radonc.2016.07.017 (ICRU) ICoRUaM, 2007, Prescribing, Recording, and Reporting Proton-Beam Therapy, ICRU Report 78. The, J ICRU, 7, 1, 10.1093/jicru_ndm021 Agency, 2000, An International Code of Practice for Dosimetry Based on Standards of Absorbed Dose to Water, Technical Reports Series, 398 ICRU. Prescribing, Recording, and Reporting Proton-Beam Therapy (ICRU Report 78). Kataria, 2012, Homogeneity Index: An objective tool for assessment of conformal radiation treatments, J Med Phys, 37, 207, 10.4103/0971-6203.103606 van't Riet, 1997, A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate, Int J Radiat Oncol Biol Phys, 37, 731, 10.1016/S0360-3016(96)00601-3 (ICRU) ICoRUaM., 2010, ICRU Report 83: Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT), J ICRU, 10 Berman, 2014, Proton reirradiation of recurrent rectal cancer: dosimetric comparison, toxicities, and preliminary outcomes, Int J Part Ther, 1, 2, 10.14338/IJPT.13-00002.1 Tatsuzaki, 1992, 3-D comparative study of proton vs. x-ray radiation therapy for rectal cancer, Int J Radiat Oncol Biol Phys, 22, 369, 10.1016/0360-3016(92)90056-N Wolff, 2012, Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications, Radiother Oncol, 102, 30, 10.1016/j.radonc.2011.10.018 Isacsson, 1996, Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer, Radiother Oncol, 41, 263, 10.1016/S0167-8140(96)01851-8 Fok, 2021, Proton beam therapy in rectal cancer: A systematic review and meta-analysis, Surg Oncol, 38, 10.1016/j.suronc.2021.101638 Wong, 2012, Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer, Int J Radiat Oncol Biol Phys, 82, 1367, 10.1016/j.ijrobp.2011.05.027 Pettersson, 2010, Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer, Br J Surg, 97, 580, 10.1002/bjs.6914 Kavanagh, 2010, Radiation dose-volume effects in the stomach and small bowel, Int J Radiat Oncol Biol Phys, 76, S101, 10.1016/j.ijrobp.2009.05.071 Hayman, 2011, Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging, Int J Radiat Oncol Biol Phys, 79, 847, 10.1016/j.ijrobp.2009.11.040 Li, 2016, Correlation between bone marrow dose volumes and acute hematological toxicity in postoperative gynecological cancer patients, Pak J Med Sci, 32, 1547, 10.12669/pjms.326.11489 Klopp, 2013, Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer, Int J Radiat Oncol Biol Phys, 86, 83, 10.1016/j.ijrobp.2013.01.017 Mell, 2008, Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy, Int J Radiat Oncol Biol Phys, 70, 1431, 10.1016/j.ijrobp.2007.08.074 Bregendahl KJE, 2015, Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population-based cross-sectional study, Colorectal Dis, 17, 26, 10.1111/codi.12758 Kronborg, 2019, Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancer, Clin Transl Radiat Oncol, 19, 72, 10.1016/j.ctro.2019.09.001 Simone, 2012, Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma, Int J Radiat Oncol Biol Phys, 82, 242, 10.1016/j.ijrobp.2010.11.021 Rombouts, 2020, Increased risk for second primary rectal cancer after pelvic radiation therapy, Eur J Cancer, 124, 142, 10.1016/j.ejca.2019.10.022 Zhu, 2018, Risk of secondary rectal cancer and colon cancer after radiotherapy for prostate cancer: a meta-analysis, Int J Colorectal Dis, 33, 1149, 10.1007/s00384-018-3114-7 Martling, 2017, Risk of second primary cancer in patients treated with radiotherapy for rectal cancer, Br J Surg, 104, 278, 10.1002/bjs.10327 Siegel, 2017, Colorectal cancer statistics, 2017, CA Cancer J Clin, 67, 177, 10.3322/caac.21395 Araghi, 2019, Changes in colorectal cancer incidence in seven high-income countries: a population-based study, Lancet Gastroenterol Hepatol, 4, 511, 10.1016/S2468-1253(19)30147-5 Appelt, 2013, Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy, Int J Radiat Oncol Biol Phys, 85, 74, 10.1016/j.ijrobp.2012.05.017 Figueiredo, 2018, Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes, Eur J Surg Oncol, 44, 484, 10.1016/j.ejso.2018.01.088 Appelt, 2015, High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, Lancet Oncol, 16, 919, 10.1016/S1470-2045(15)00120-5